Search Within

Charles Rudin

Formats
  1. Journal Article (243)
  2. Meeting Abstract (223)
  3. Review (11)
  4. Editorial (10)
  5. Book Section (3)
  6. Guidelines (2)
  7. Research Letter (2)
  8. Correspondence (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (495)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (495)
  3. Department of Medicine (495)
  4. GSK Faculty (495)
  5. Solid Tumor Oncology Division (495)
  6. Thoracic Oncology (495)

More Groups

People
  1. Mark Kris (100)
  2. Natasha Rekhtman (96)
  3. Marc Ladanyi (93)
  4. Gregory Riely (76)
  5. Bob Li (72)
  6. Elisa De Stanchina (70)

More People

Years
  1. 2025 (18)
  2. 2024 (48)
  3. 2023 (43)
  4. 2022 (59)
  5. 2021 (52)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (83)
  2. Journal of Thoracic Oncology (79)
  3. Clinical Cancer Research (33)
  4. Cancer Research (31)
  5. Annals of Oncology (30)
  6. Cancer Discovery (15)

More Publications

Publishers
  1. Elsevier Inc. (105)
  2. American Society of Clinical Oncology (93)
  3. American Association for Cancer Research (86)
  4. Nature Publishing Group (45)
  5. Oxford University Press (40)
  6. Cell Press (28)

More Publishers

Results (495)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiomic profiling of patient-derived xenografts established from patients with malignant pleural mesothelioma proposes pathways associated with poor prognosis
    Meeting Abstract

    Offin, M.; Sauter, J. L.; Egger, J. V.; deStanchina, E.; Poirier, J. T.; Zauderer, M. G.; Rudin, C.; Sen, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting LSD1 rescues MHC-I antigen presentation in small cell lung cancer
    Meeting Abstract

    Nguyen, M. N.; Taniguchi, H.; Chow, A.; Zhan, Y. A.; Sen, T.; Rudin, C. M.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; Egger, J.; Qiu, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SKYSCRAPER-02: Primary results of a phase III, randomized, double-blind, placebo-controlled study of atezolizumab (atezo) + carboplatin + etoposide (CE) with or without tiragolumab (tira) in patients (pts) with untreated extensive-stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Rudin, C. M.; Liu, S. V.; Lu, S.; Soo, R. A.; Hong, M. H.; Lee, J. S.; Bryl, M.; Dumoulin, D. W.; Rittmeyer, A.; Chiu, C. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Durvalumab (D) + platinum-etoposide (EP) in 1L extensivestage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN
    Meeting Abstract

    Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; Stewart, R.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Phase II, multicenter, randomized, open-label study of DS-7300 in patients (pts) with pre-treated extensive-stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Paz-Ares, L.; Johnson, M. L.; Girard, N.; Hann, C. L.; Ahn, M. J.; Nishio, M.; Godard, J.; Laadem, A.; Yoshizuka, N.; Qian, M.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
    Journal Article

    Selenica, P.; Marra, A.; Choudhury, N. J.; Gazzo, A.; Falcon, C. J.; Patel, J.; Pei, X.; Zhu, Y.; Ng, C. K. Y.; Curry, M.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • 1L durvalumab (D) + platin-etoposid (EP) beim fortgeschrittenen kleinzelligen lungenkarzinom (ES-SCLC): Explorative analyse der molekularen SCLC-subtypen in der caspian-studie
    Meeting Abstract

    Schulz, C.; Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and mutational landscape of BRAF(V600E)-mutant non-small cell lung carcinoma
    Meeting Abstract

    Sui, J. S. Y.; Ladanyi, M.; Rudin, C. M.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Offin, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Egger, J. V.; Bhanot, U.; Qiu, J.; De Stanchina, E.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save